Literature DB >> 24502029

Platelet indices in patients with de novo portal vein thrombosis and liver cirrhosis.

Irina Gîrleanu1, Anca Trifan2, Camelia Cojocariu2, Mihaela Dimache2, Ana-Maria Sîngeap2, Oana Stoica2, C Sfarti2, C Stanciu2.   

Abstract

UNLABELLED: Platelet indices are markers of platelet reactivity used for thrombotic risk assessment in patients with cardiovascular diseases, and recently in venous thrombosis. AIM: To assess the diagnostic value of platelet indices in patients with non-malignant de novo portal vein thrombosis and liver cirrhosis.
MATERIAL AND METHODS: We conducted a prospective, case-control study on patients admitted to a tertiary center in the interval January, 2010 - December, 2012. Included in the study were 54 patients with portal vein thrombosis (PVT) and 54 controls. Patients with known malignancy, sepsis, thrombophilia, on anticoagulant or antiaggregant therapy, acute or chronic inflammatory diseases, severe anemia, renal failure, acute coronary syndrome, and chronic pulmonary disease were excluded from the study.
RESULTS: Both groups were comparable for baseline characteristics. Mean platelet volume, platelet distribution width (PDW) and plateletcrit were higher in the PVT group. In a multivariate logistic regression analysis, significant predictors of the presence of PVT were mean platelet volume (MPV), PDW, and procalcitonin (PCT).
CONCLUSION: Our data suggest that increased platelet indices contribute to the prethrombotic state in liver cirrhosis and that larger platelets may play a specific role in thrombosis despite thrombocytopenia.

Entities:  

Mesh:

Year:  2013        PMID: 24502029

Source DB:  PubMed          Journal:  Rev Med Chir Soc Med Nat Iasi        ISSN: 0048-7848


  5 in total

1.  Predictive Effect of Mean Platelet Volume in Patients with Portal Vein Thrombosis: A Meta-analysis of Case-control Studies.

Authors:  Wen-Yi Lin; Xuan Lu; Feng-Juan Fan; Yu Hu
Journal:  Curr Med Sci       Date:  2018-08-20

2.  Evaluation of Platelet Indices in Patients with Splanchnic Vein Thrombosis.

Authors:  Saniya Sharma; Narender Kumar; Ishwar Bihana; Varun Uppal; Jasmina Ahluwalia; Shano Naseem; Neelam Varma; Surinder Singh Rana
Journal:  Indian J Hematol Blood Transfus       Date:  2021-04-13       Impact factor: 0.915

3.  Risk Factors of Portal Vein Thrombosis after Devascularization Treatment in Patients with Liver Cirrhosis: A Nested Case-Control Study.

Authors:  Shenxin Lu; Guohua Hu; Shiyao Chen; Jian Wang
Journal:  Biomed Res Int       Date:  2020-08-27       Impact factor: 3.411

4.  Increased portal vein diameter is predictive of portal vein thrombosis development in patients with liver cirrhosis.

Authors:  Gang Dong; Xiao-Quan Huang; Yu-Li Zhu; Hong Ding; Feng Li; Shi-Yao Chen
Journal:  Ann Transl Med       Date:  2021-02

5.  Platelet count and indices as postpartum hemorrhage risk factors: a retrospective cohort study.

Authors:  Wobke E M van Dijk; Jelle S Nijdam; Saskia Haitjema; Mark C H de Groot; Albert Huisman; Marieke C Punt; Annemiek C C Evers; Roger E G Schutgens; A Titia Lely; Karin P M van Galen
Journal:  J Thromb Haemost       Date:  2021-08-20       Impact factor: 16.036

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.